Discover what is changing in liver cancer. The Liver Cancer Summit 2027 will showcase the scientific and clinical advances that are redefining our understanding of primary liver cancers, from disease mechanisms and tumour biology to diagnosis, treatment, and long-term patient care. Explore the latest developments in early detection and prevention, spatial analysis, real-world evidence, and next-generation therapies, and gain insights into the innovations that are shaping the future of hepatobiliary oncology.

Translate progress into practice and connect with a multidisciplinary community. Engage with new evidence, emerging treatment strategies, and ongoing studies that are influencing tomorrow’s standards of care, while considering how these advances can be meaningfully applied in real-world clinical settings. Through expert-led sessions, oral abstract presentations, poster presentations and interactive discussions, the EASL Liver Cancer Summit offers a unique opportunity to connect with clinicians, researchers, allied health professionals and patient representatives, from across the liver cancer landscape, fostering collaboration and a shared commitment to improving outcomes for patients with liver cancer.

The Liver Cancer Summit 2027 will provide a comprehensive overview of the latest advances in primary liver cancers, spanning basic, translational, and clinical research. The programme will explore the entire continuum of liver cancer, from prevention and early detection to innovative treatment strategies and long-term patient management. Through multidisciplinary sessions covering tumour biology, the tumour microenvironment, novel diagnostic technologies, precision oncology, real-world evidence, and emerging therapeutic approaches, the EASL Liver Cancer Summit aims to bridge scientific discovery and clinical practice, fostering collaboration and accelerating progress towards better outcomes for patients with liver cancer.

By the end of the EASL Liver Cancer Summit 2027, participants will be able to:

• Review the latest scientific and clinical advances reshaping the understanding, diagnosis, and management of primary liver cancers.
• Interpret emerging evidence on tumour biology, immune mechanisms, resistance, biomarkers, and personalised therapeutic strategies.
• Assess current and future approaches to multidisciplinary care, including surgical, locoregional, systemic, and supportive treatment pathways.
• Apply new knowledge to complex clinical decision-making, taking into account liver function, tumour characteristics, patient needs, quality of life, and healthcare resources.
• Explore how translational research, innovative clinical trials, and real-world data can accelerate progress and improve outcomes for patients with liver cancer.

• DISCOVER WHAT IS CHANGING

Explore the scientific and clinical advances that are redefining our understanding of primary liver cancer, from disease mechanisms and tumour biology to diagnosis, treatment, and long-term patient care.

• TRANSLATE PROGRESS INTO PRACTICE

Engage with new evidence, emerging strategies, and ongoing studies that are shaping tomorrow’s standards, while considering how innovation can be meaningfully applied in real-world clinical settings.

• JOIN A MULTIDISCIPLINARY COMMUNITY

Connect with colleagues from across the liver cancer landscape in an open and collaborative environment where different perspectives, specialties, and experiences come together around a shared mission.